World's Best Scientists 2026 revealed!
Anders Sönnerborg

Anders Sönnerborg

D-Index & Metrics

Immunology

D-Index
85
Citations
30738
World Ranking
1305
National Ranking
23

Medicine

D-Index
85
Citations
30837
World Ranking
14484
National Ranking
270

Overview

Anders Sönnerborg is affiliated with the Karolinska Institute in Sweden. Their research primarily spans the fields of Medicine and Immunology and Microbiology. Within these, notable subfields include Infectious Diseases, Virology, Immunology, Molecular Biology, and Emergency Medicine.

The scientist has contributed extensively to topics such as HIV Research and Treatment, HIV/AIDS drug development and treatment, HIV/AIDS Research and Interventions, COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, HIV-related health complications and treatments, and Long-Term Effects of COVID-19.

Frequent venues for publishing research include bioRxiv (Cold Spring Harbor Laboratory), Clinical Infectious Diseases, HIV Medicine, SSRN Electronic Journal, and Research Square (Research Square).

Among recent notable papers are:

  • Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19, 2020, Cell
  • Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19, 2021, JAMA
  • Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19, 2020, bioRxiv (Cold Spring Harbor Laboratory)
  • MAIT cell activation and dynamics associated with COVID-19 disease severity, 2020, Science Immunology
  • Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severity, 2021, Proceedings of the National Academy of Sciences

Frequent co-authors who have collaborated with Anders Sönnerborg include:

  • Maurizio Zazzi
  • Piotr Nowak
  • Ujjwal Neogi
  • Soo Aleman
  • Kristoffer Strålin

Best Publications

  • Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study

    Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka

  • Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19.

    Takuya Sekine;André Perez-Potti;Olga Rivera-Ballesteros;Kristoffer Strålin

  • Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis C

    Olle Reichard;Gunnar Norkrans;Aril Frydén;Jean-Henrik Braconier

  • Late presentation of HIV infection: a consensus definition

    A Antinori;T Coenen;D Costagiola;N Dedes

  • Gut Microbiota Linked to Sexual Preference and HIV Infection.

    Marc Noguera-Julian;Marc Noguera-Julian;Muntsa Rocafort;Yolanda Guillén;Javier Rivera

  • Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection.

    Angelo De Milito;Anna Nilsson;Kehmia Titanji;Rigmor Thorstensson

  • Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infection

    Edwin Leeansyah;Anupama Ganesh;Máire F. Quigley;Anders Sönnerborg

  • Gut microbiota diversity predicts immune status in HIV-1 infection.

    Nowak P;Troseid M;Avershina E;Barqasho B

  • T-bet and Eomes Are Differentially Linked to the Exhausted Phenotype of CD8+ T Cells in HIV Infection

    Marcus Buggert;Johanna Tauriainen;Takuya Yamamoto;Juliet Wairimu Frederiksen

  • European guidelines on the clinical management of HIV-1 tropism testing

    L.P.R. Vandekerckhove;Annemarie Wensing;Rolf Kaiser;F. Brun-Vézinet

  • Loss of memory (CD27) B lymphocytes in HIV-1 infection.

    De Milito A;Mörch C;Sönnerborg A;Chiodi F

  • Transmission of Drug-Resistant HIV-1 Is Stabilizing in Europe

    Jurgen Vercauteren;Annemarie M. J. Wensing;David A. M. C. van de Vijver;Jan Albert

  • Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study

    John Gregson;Michele Tang;Nicaise Ndembi;Raph L Hamers

  • Interferon-alpha and tumor necrosis factor-alpha in serum of patients in various stages of HIV-1 infection

    Madeleine von Sydow;Anders Sönnerborg;Hans Gaines;Örjan Strannegård

  • Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19

    Takuya Sekine;André Perez-Potti;Olga Rivera-Ballesteros;Kristoffer Strålin

  • Antibody response in primary human immunodeficiency virus infection.

    Hans Gaines;Hans Gaines;Anders Sönnerborg;Anders Sönnerborg;Jan Czajkowski;Jan Czajkowski;Francesca Chiodi;Francesca Chiodi

  • Arming of MAIT Cell Cytolytic Antimicrobial Activity Is Induced by IL-7 and Defective in HIV-1 Infection.

    Edwin Leeansyah;Jenny Svärd;Joana Dias;Marcus Buggert

  • Feasibility and Effectiveness of Indicator Condition-Guided Testing for HIV: Results from HIDES I (HIV Indicator Diseases across Europe Study)

    Ann K. Sullivan;Dorthe Raben;Joanne Reekie;Michael Rayment

  • Limited humoral immunity in hepatitis C virus infection.

    Margaret Chen;Matti Sällberg;Anders Sönnerborg;Ola Weiland

  • Identification of a novel specific CYP2B6 allele in Africans causing impaired metabolism of the HIV drug efavirenz.

    Jue Wang;Anders Sönnerborg;Anders Rane;Filip Josephson

  • Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection.

    B Wahren;L Morfeldt-Månsson;G Biberfeld;L Moberg

Frequent Co-Authors

Jan Albert
Jan Albert Karolinska Institute
Anne-Mieke Vandamme
Anne-Mieke Vandamme Rega Institute for Medical Research
Maurizio Zazzi
Maurizio Zazzi University of Siena
Magnus Gisslén
Magnus Gisslén Sahlgrenska University Hospital
Ola Weiland
Ola Weiland Karolinska University Hospital
Rolf Kaiser
Rolf Kaiser University of Cologne
Charles A. Boucher
Charles A. Boucher Erasmus University Rotterdam
Johan K. Sandberg
Johan K. Sandberg Karolinska University Hospital
Roger Paredes
Roger Paredes University of Vic - Central University of Catalonia
David A. M. C. van de Vijver
David A. M. C. van de Vijver Erasmus University Rotterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, related online degrees can open diverse career pathways in healthcare and research. Nursing professionals can significantly benefit from specialized programs like the cheapest psych np programs online, which provide affordable options for advanced practice focusing on mental health – a key area overlapping with immunological disorders.

Considering salary potential is crucial when exploring further education. Some of the highest paid dnp specialties offer attractive financial incentives, notably those that focus on acute care and complex patient populations impacted by immune system diseases.

Nurses aiming to expand their expertise may follow a transition from family nursing to acute care through structured programs discussed in fnp to acnp pathways. This is particularly relevant for immunologists working in clinical settings where acute care knowledge enhances patient management.

For those seeking expedited training, enrolling in the accelerated fnp program can fast-track nurse practitioners, making it easier to enter immunology-related healthcare roles swiftly without compromising on educational quality.

Best Scientists Citing Anders Sönnerborg

Trending Scientists